Cases & Deals

Sanofi sells Dermik dermatology unit to Valeant Pharmaceuticals for $425 million

Clients Sanofi

Jones Day advised Sanofi in the sale of its Dermik dermatology unit to Valeant Pharmaceuticals International Inc. for $425 million. Dermik has a significant presence in the medical dermatology market in the United States and Canada.

In addition to M&A representation, Jones Day provided intellectual property, antitrust, and employee benefits advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.